Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients.
Fang C, Fang W, Xu L, Gao F, Hou Y, Zou H, Ma Y, Moll JM, Yang Y, Wang D, Huang Y, Ren H, Zhao H, Qin S, Zhong H, Li J, Liu S, Yang H, Wang J, Brix S, Kristiansen K, Zhang L.
Fang C, et al. Among authors: zhang l.
Front Oncol. 2022 Apr 21;12:837525. doi: 10.3389/fonc.2022.837525. eCollection 2022.
Front Oncol. 2022.
PMID: 35530307
Free PMC article.